CV Therapeutics
Foster City, US · 10 known investors
Gilead discovers, develops, and delivers innovative therapeutics for people with life-threatening diseases, focusing on virology, oncology, and inflammation across more than 35 countries. The company combines scientific rigor with global partnerships and licensing programs to expand access to medicines worldwide.
Founders & leadership
LL
Lou LangeFounder
Investors · 10
Aisling CapitalNew York
Asset Management CompanyMenlo Park · $500K – $2M
Frazier Life SciencesPalo Alto
Longitude CapitalMenlo Park · $10M – $30M
Lumira VenturesToronto · $1M – $10M
Menlo VenturesSan Francisco · $1M – $20M
Monograph Capital PartnersLondon
Ridgeback CapitalMiami
RiverVest Venture PartnersSt. Louis · $500K – $3M
VantagePoint Capital PartnersSilicon Valley · $2M – $100M